The evidence supports a viral aetiology for primary biliary cirrhosis

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 50, Issue 4, Pages (April 2009)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Autoimmune liver disease, autoimmunity and liver transplantation

Primary prevention of variceal haemorrhage: A pharmacological approach

Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou

Volume 61, Issue 6, Pages (December 2014)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Reactive oxygen species in the normal and acutely injured liver

Volume 127, Issue 6, Pages (December 2004)

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

NS5A inhibitors in the treatment of hepatitis C

Immigration and viral hepatitis

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

David G. Bowen, Christopher M. Walker Journal of Hepatology

European Association for the Study of the Liver Journal of Hepatology

Mesenchymal stromal cell therapy for liver diseases

The place of downstaging for hepatocellular carcinoma

AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Primary biliary cirrhosis: A 2010 update

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 45, Issue 4, Pages (October 2006)

Volume 62, Issue 3, Pages (March 2015)

Genomic risk of hepatitis C-related hepatocellular carcinoma

Unmet clinical need in autoimmune liver diseases

Autophagy in the liver Journal of Hepatology

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Volume 61, Issue 1, Pages S45-S57 (November 2014)

Volume 57, Issue 5, Pages (November 2012)

Volume 50, Issue 4, Pages (April 2009)

Liver stem cells—prospects for clinical use

Paul C. Adams, James C. Barton Journal of Hepatology

Volume 56, Issue 6, Pages (June 2012)

Immigration and viral hepatitis

Evolution of liver transplantation for hepatocellular carcinoma

Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability Markus Cornberg,

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

The impact of intestinal microflora on serum bilirubin levels

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection Isabelle Chemin,

The use of hemospray in portal hypertensive bleeding; a case series

Volume 62, Issue 3, Pages (March 2015)

Volume 66, Issue 4, Pages (April 2017)

Volume 42, Issue 4, Pages (April 2005)

Liver transplantation in children

Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Corrigendum to “Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury” [J Hepatol 49 (2008) 88–98] Angela Douglass,

Volume 44, Issue 1, Pages (January 2006)

Volume 50, Issue 1, Pages 4-6 (January 2009)

Niya Aleksieva, Stuart J. Forbes Journal of Hepatology

Outcomes in liver transplantation: Does sex matter?

Volume 64, Issue 6, Pages (June 2016)

Presentation transcript:

The evidence supports a viral aetiology for primary biliary cirrhosis Andrew L. Mason Journal of Hepatology Volume 54, Issue 6, Pages 1312-1314 (June 2011) DOI: 10.1016/j.jhep.2010.12.009 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Detection of human Betaretrovirus proteins in PBC lymph node. Immunochemistry studies of lymph nodes showing (A) anti-MMTV p27 capsid antibody and (B) anti-MMTV gp52 surface antibody in consecutive layers of PBC lymph node, whereas (C) normal lymph node has no anti-MMTV p27 capsid antibody staining [H&E 200×]. Journal of Hepatology 2011 54, 1312-1314DOI: (10.1016/j.jhep.2010.12.009) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions